Single institutional experience of peripheral applications of a liquid embolic agent: Ethylene Vinyl Alcohol Copolymer

Abstract

Objective To evaluate the safety and efficacy of ethylene vinyl alcohol (EVOH) copolymer for the treatment of a variety of peripheral vascular pathologies. Results Between October 2010 and October 2017, 43 patients who underwent total 54 EVOH embolization procedures for the treatment of peripheral vascular pathologies were included. The cases which involved the use of EVOH for the treatment of nonvascular, neurologic, ophthalmologic, otolaryngologic or head-neck pathologies were excluded. The demographic data, technical and clinical success rates, and procedure-related details and complications were obtained. The most common indications for EVOH embolization were type II endoleaks ( n = 18) and peripheral arteriovenous malformations ( n = 14). The majority of cases (62.5%) used EVOH without any adjunct embolic material. The results of this study showed 100% technical success rates and 89% clinical success rates. No events of nontarget embolization or other procedure-related complications were noted. The mortality & morbidity rates were 0%. The loss to follow up rate was 16% (9 /54). The mean follow-up period was 134 days (range, 30 to 522 days). Conclusion The single institutional experience supports the safety and efficacy of EVOH embolization in the treatment of various peripheral vascular conditions.

How I Do It: Endovascular Management of Acute Nonvariceal Gastrointestinal Bleeding

“…77 The use of n-BCA alone as an embolic is limited owing to the lack of control when delivering it and steep learning curve for operator use. 78 It is commonly used for thrombosis of large aneurysms or when coiling is insufficient to cause blood stasis. However, there has been an increase in the use of n-BCA for managing LGIB.…”

Balloon occlusion as an adjunctive technique during sclerotherapy of Puig's classified advanced venous malformations

“…6 Combined utilization of sclerotherapy and embolotherapy techniques during treatment of peripheral vascular malformations has the potential to achieve zero occurrences of non-target embolization in experienced operators' hands. 7,8 Nevertheless, no sclerosing agent is immune to the potential risk of non-target embolization, especially in the setting of larger caliber draining veins. 9 Balloon occlusion offers a means of temporarily blocking these connections to the systemic circulation to allow for more complete sclerotherapy in addition to reducing the risk of non-target venous occlusion.…”

Use of Ethylene Vinyl Copolymer for Embolization Outside the Central Nervous System: A Case Review

“…1 In a single center review, Onyx had an 89% clinical success rate in a variety of conditions, including aortic stent graft endoleaks, peripheral AVMs, and hemorrhage. 2 Mahdjoub et al reported 100% efficacy in treating renal hemorrhage in 24 patients. 3 Mozes et al reported successful treatment of type II endoleaks in aortic stent grafts in 72% of patients.…”